Human papillomavirus l1 protein virus like particles

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

223 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Papillomavirus infections	D030361	—	—	—	—	2	1	2	5
Papillomavirus vaccines	D053918	—	—	—	—	1	1	—	2
Hiv infections	D015658	EFO_0000764	B20	—	—	—	1	—	1
Acquired immunodeficiency syndrome	D000163	EFO_0000765	B20	—	—	—	1	—	1

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Infections	D007239	EFO_0000544	—	—	—	1	—	—	1

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Uterine cervical dysplasia	D002578	EFO_1000910	N87	1	1	—	—	—	1

Indications Phases 1

No data

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Spontaneous abortion	D000022	EFO_1001255	O00.1	—	—	—	—	1	1
Uterine cervical neoplasms	D002583	—	—	—	—	—	—	1	1

Epidemiology

Epidemiological information for investigational and approved indications

Drug

General

Drug common name	—
INN	—
Description	—
Classification	Unknown
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	—